학술논문

Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9–50 years: a randomised, controlled, phase 2, non-inferiority study
Document Type
Article
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, June 2022, 22(6):901-911)
Subject
Language
English
ISSN
14744457
14733099